BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19757763)

  • 1. The human papillomavirus vaccine: an oncology nursing issue.
    Buick C; Metcalfe K
    Can Oncol Nurs J; 2009; 19(2):60-4. PubMed ID: 19757763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
    Lee FH; Paz-Soldan VA; Carcamo C; Garcia PJ
    J Low Genit Tract Dis; 2010 Apr; 14(2):113-7. PubMed ID: 20354419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J; Tuma R; Zarfati D; Ophir E
    Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine treats cervical cancer.
    Radiol Technol; 2008; 79(6):579-81. PubMed ID: 18650537
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.
    Bogaards JA; Coupé VM; Xiridou M; Meijer CJ; Wallinga J; Berkhof J
    Epidemiology; 2011 Jul; 22(4):505-15. PubMed ID: 21540743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
    Dillner J; Brown DR
    Expert Rev Mol Med; 2004 Apr; 6(9):1-21. PubMed ID: 15096282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.
    Yuanyue L; Baloch Z; Shanshan L; Yasmeen N; Xiaomei W; Khan JM; Xueshan X
    Cancer Control; 2018; 25(1):1073274818799306. PubMed ID: 30213198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?
    Low GM; Attiga YS; Garg G; Schlegal R; Gallicano GI
    Viral Immunol; 2012 Jun; 25(3):174-86. PubMed ID: 22691099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
    Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
    Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
    Six L; Joura EA
    Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?
    Liu X; Feng A; Cui Y; Tobe RG
    Biosci Trends; 2013 Aug; 7(4):159-67. PubMed ID: 24056165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus quadrivalent vaccine: a look behind the numbers.
    Flaherty DK; Alkhateeb FM
    Ann Pharmacother; 2009 Apr; 43(4):740-4. PubMed ID: 19276314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.